Effectiveness of Creatine Supplementation and Exercise on Muscle and Bone
NCT ID: NCT01057680
Last Updated: 2012-12-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
90 participants
INTERVENTIONAL
2010-01-31
2012-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We hypothesize that creatine supplementation will increase muscle mass, strength, and bone mineral density more than placebo.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
creatine
This arm will involve creatine supplementation 0.1 g per kg body mass per day while participating in a resistance training program (1 hour per day, 3 days per week).
creatine monohydrate
Powder, 0.1 g per day, 12 months
Sugar
This arm will involve placebo (maltodextrin) given every day while the participant does a resistance training program (1 hour per day, 3 days per week).
sugar placebo
powder, 0.1 g/day, 12 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
creatine monohydrate
Powder, 0.1 g per day, 12 months
sugar placebo
powder, 0.1 g/day, 12 months
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* males or postmenopausal females
* not currently participating in resistance training
Exclusion Criteria
* previous fragility fractures
* history of taking medications that affect bone mineral density in the past year including bisphosphonates, parathyroid hormone, calcitonin, hormone replacement therapy, or corticosteroids (i.e. within the past year)
* suffer from severe osteoarthritis
* have taken creatine supplementation within the past 6 months
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Saskatchewan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Phil Chilibeck
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philip Chilibeck, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Saskatchewan
Darren Candow, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Regina
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Kinesiology and Health Sciences
Regina, Saskatchewan, Canada
College of Kinesiology, University of Saskatchewan
Saskatoon, Saskatchewan, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Candow DG, Chilibeck PD, Gordon JJ, Kontulainen S. Efficacy of Creatine Supplementation and Resistance Training on Area and Density of Bone and Muscle in Older Adults. Med Sci Sports Exerc. 2021 Nov 1;53(11):2388-2395. doi: 10.1249/MSS.0000000000002722.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-169
Identifier Type: -
Identifier Source: org_study_id